DAFNA Capital Management »

iShares NASDAQ Biotechnology Index shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 103k 144.37
2025-06-30 $13M 103k 126.51
2025-03-31 $13M 103k 127.90
2024-12-31 $14M 103k 132.21
2024-09-30 $15M 103k 145.60
2024-06-30 $14M 103k 137.26
2024-03-31 $14M 103k 137.22
2023-12-31 $14M 103k 135.85
2023-09-30 $13M 103k 122.29
2023-06-30 $13M 103k 126.96
2023-03-31 $13M 103k 129.16
2022-12-31 $14M 103k 131.29
2022-09-30 $12M 103k 116.96
2022-06-30 $12M 103k 117.63
2022-03-31 $13M 103k 130.30
2021-12-31 $6.2M 41k 152.62
2021-09-30 $6.6M 41k 161.69
2021-06-30 $6.7M 41k 163.64
2021-03-31 $6.1M 40k 150.57
2020-12-31 $7.2M 47k 151.50
2020-09-30 $7.6M 56k 135.40
2020-06-30 $7.5M 55k 136.68
2020-03-31 $7.9M 73k 107.74
2019-12-31 $7.8M 65k 120.51
2019-09-30 $6.5M 65k 99.51
2019-06-30 $6.7M 61k 109.10
2019-03-31 $6.9M 61k 111.81
2018-12-31 $6.3M 65k 96.43
2018-09-30 $3.2M 26k 121.95
2018-06-30 $2.9M 26k 109.81
2018-03-31 $2.8M 26k 106.74
2017-12-31 $2.8M 26k 106.78
2017-09-30 $2.9M 8.7k 333.56
2017-06-30 $2.7M 8.7k 310.11
2017-03-31 $2.6M 8.7k 293.22
2016-12-31 $2.3M 8.7k 265.40
2016-06-30 $1.5M 6.0k 257.33
2016-03-31 $1.6M 6.0k 260.83

More positions owned by DAFNA Capital Management

Stereotaxis Com New (STXS)
Spdr S&p Biotech Etf Etf (XBI)
Revolution Medicines (RVMD)
Cytokinetics Com New (CYTK)
AtriCure (ATRC)
Merus N V (MRUS)
Ishares Nasdaq Biotech Indx Etf (IBB)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Xenon Pharmaceuticals (XENE)
Neurocrine Biosciences (NBIX)
Arcus Biosciences Incorporated (RCUS)
Syndax Pharmaceuticals (SNDX)
Day One Biopharmaceuticals I (DAWN)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for DAFNA Capital Management

Top funds holding iShares NASDAQ Biotechnology Index

Morgan Stanley
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
UBS Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Commerce Bank N A
Wells Fargo & Company
Royal Bank of Canada
Calamos Advisors
Jane Street
Citadel Advisors
Leucadia National Corporation
Barclays

View all funds holding iShares NASDAQ Biotechnology Index